Valuation Dr. Reddy's Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:23:37 2026-09-18 EDT			5-day change	1st Jan Change
1,171.10 ^INR	-0.08%		+0.87%	-7.86%

09-18	Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up Marginally for Week	MT
09-18	Dr. Reddy's Laboratories Limited and Takeda Biopharmaceuticals India Private Limited Enter into Exclusive Distribution and Marketing Agreement for Qdenga in India	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	714,500	767,655	1,024,969	953,168	1,044,616	975,508	-	-
Change	-	7.44%	33.52%	-7.01%	9.59%	-6.62%	-	-
Enterprise Value (EV) ¹	703,980	719,330	960,383	928,633	1,011,902	943,926	923,890	893,453
Change	-	2.18%	33.51%	-3.31%	8.97%	-6.72%	-2.12%	-3.29%
P/E	30.4x	17.1x	18.4x	16.9x	24.4x	25.9x	20.1x	16.9x
PBR	3.76x	3.33x	3.63x	2.86x	2.78x	2.4x	2.17x	1.96x
PEG	-	0.2x	0.8x	13.12x	-1x	-2.1x	0.7x	0.9x
Capitalization / Revenue	3.33x	3.11x	3.67x	2.93x	3.11x	2.77x	2.48x	2.25x
EV / Revenue	3.28x	2.92x	3.44x	2.85x	3.01x	2.68x	2.35x	2.06x
EV / EBITDA	13.7x	11.1x	12.1x	10.8x	15.1x	15.2x	11.5x	9.73x
EV / EBIT	20.5x	13.8x	14.8x	13.4x	21.8x	22.7x	16.1x	13.3x
EV / FCF	52.3x	15.1x	33.1x	49.1x	30.3x	23.8x	25.4x	18.4x
FCF Yield	1.91%	6.61%	3.02%	2.04%	3.3%	4.2%	3.93%	5.44%
Dividend per Share ²	6	8	8	8	8	7.543	8.39	9.097
Rate of return	0.7%	0.87%	0.65%	0.7%	0.64%	0.64%	0.72%	0.78%
EPS ²	28.34	54.18	66.92	67.78	51.42	45.16	58.21	69.15
Distribution rate	21.2%	14.8%	12%	11.8%	15.6%	16.7%	14.4%	13.2%
Net sales ¹	214,391	246,697	279,164	325,535	335,933	351,836	392,708	432,883
EBITDA ¹	51,400	64,559	79,481	86,236	67,048	62,039	80,037	91,863
EBIT ¹	34,277	52,057	64,781	69,178	46,443	41,599	57,469	67,323
Net income ¹	23,568	45,073	55,779	56,544	42,850	37,212	48,996	57,689
Net Debt ¹	-10,520	-48,325	-64,586	-24,535	-32,714	-31,582	-51,618	-82,055
Reference price ²	861.08	924.30	1,231.03	1,144.05	1,254.65	1,171.10	1,171.10	1,171.10
Nbr of stocks (in thousands)	829,771	830,526	832,611	833,152	832,596	832,984	-	-
Announcement Date	5/19/22	5/10/23	5/7/24	5/9/25	5/12/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DR. REDDY'S LABORATORIES LIMITED	25.93x	2.68x	15.22x	0.64%	10.17B
ELI LILLY AND COMPANY	32.77x	11.91x	24.15x	0.6%	1,028B
JOHNSON & JOHNSON	30.03x	6.68x	18.7x	1.99%	651B
ABBVIE INC.	33.38x	7.81x	16.15x	2.6%	466B
ROCHE HOLDING AG	19.33x	4.72x	11.71x	2.81%	346B
NOVARTIS AG	19.72x	5.16x	12.79x	3.11%	266B
ASTRAZENECA PLC	21.26x	4.42x	12.58x	1.99%	259B
AMGEN INC.	24.43x	6.42x	11.43x	2.62%	208B
NOVO NORDISK A/S	12.52x	4.56x	9.46x	4.01%	191B
GILEAD SCIENCES, INC.	-45.4x	6.61x	25.81x	2.19%	186B
Average	17.40x	6.10x	15.80x	2.26%	361.19B
Weighted average by Cap.	23.68x	7.71x	17.82x	1.98%